✦ LIBER ✦

The Gynecologic Oncology Group's role in the treatment of recurrent cervix cancer: Current clinical trials

✍ Scribed by Robert L. Coleman

Book ID: 113961601
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 333 KB
Volume: 110
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2008.04.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of nab-paclitaxel in the

Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study

✍ David S. Alberts; John A. Blessing; Lisa M. Landrum; David P. Warshal; Lainie P. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Recent Achievements and Future Developme

Recent Achievements and Future Developments in Advanced and Recurrent Cervical Cancer: Trials of the Gynecologic Oncology Group

✍ Krishnansu S. Tewari; Bradley J. Monk 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 496 KB

A Phase II Trial of CPT-11 in Recurrent

A Phase II Trial of CPT-11 in Recurrent Squamous Carcinoma of the Cervix: A Gynecologic Oncology Group Study

✍ Katherine Y. Look; John A. Blessing; Charles Levenback; Matthew Kohler; Weldon C 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Phase II clinical trial of capecitabine

Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: A gynecologic oncology group study

✍ Agustin A. Garcia; John A. Blessing; Kathleen M. Darcy; Heinz Josef Lenz; Wu Zha 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phase II trial of cetuximab in the treat

Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or nonsquamous cell carcinoma of the cervix: A Gynecologic Oncology Group study

✍ A. Santin; G. Patricia; M. Sill; D. McMeekin; M. Leitao; J. Brown; G. Sutton; L. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Mitoxantrone in the treatment of advance

Mitoxantrone in the treatment of advanced non-squamous carcinoma of the cervix (A phase II trial of the gynecologic oncology group)

✍ Hyman B. Muss; Brian N. Bundy; Howard D. Homesley; George Wilbanks 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 247 KB

Twenty-five evaluable patients with advanced non-squamous carcinoma of the uterine cervix were treated with mitoxantrone 12 mg/m 2 every three weeks. All patients had good performance status and measurable disease and'only 11 had received prior chemotherapy. One complete and one partial response wer